Cargando…
Physical Enhancement? Nanocarrier? Current Progress in Transdermal Drug Delivery
A transdermal drug delivery system (TDDS) is a method that provides drug adsorption via the skin. TDDS could replace conventional oral administration and blood administration because it is easily accessible. However, it is still difficult to design efficient TDDS due to the high barrier property of...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911274/ https://www.ncbi.nlm.nih.gov/pubmed/33525364 http://dx.doi.org/10.3390/nano11020335 |
_version_ | 1783656302991376384 |
---|---|
author | Uchida, Noriyuki Yanagi, Masayoshi Hamada, Hiroki |
author_facet | Uchida, Noriyuki Yanagi, Masayoshi Hamada, Hiroki |
author_sort | Uchida, Noriyuki |
collection | PubMed |
description | A transdermal drug delivery system (TDDS) is a method that provides drug adsorption via the skin. TDDS could replace conventional oral administration and blood administration because it is easily accessible. However, it is still difficult to design efficient TDDS due to the high barrier property of skin covered with stratum corneum, which inhibits the permeation of drug molecules. Thus far, TDDS methods by applying physical stimuli such as microneedles and chemical stimuli such as surfactants have been actively developed. However, it has been hard to avoid inflammation at the administration site because these methods partially destroy the skin tissue. On the other hand, TDDS with nanocarriers minimizing damage to the skin tissues has emerged together with the development of nanotechnology in recent years. This review focuses on current trends in TDDS. |
format | Online Article Text |
id | pubmed-7911274 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-79112742021-02-28 Physical Enhancement? Nanocarrier? Current Progress in Transdermal Drug Delivery Uchida, Noriyuki Yanagi, Masayoshi Hamada, Hiroki Nanomaterials (Basel) Review A transdermal drug delivery system (TDDS) is a method that provides drug adsorption via the skin. TDDS could replace conventional oral administration and blood administration because it is easily accessible. However, it is still difficult to design efficient TDDS due to the high barrier property of skin covered with stratum corneum, which inhibits the permeation of drug molecules. Thus far, TDDS methods by applying physical stimuli such as microneedles and chemical stimuli such as surfactants have been actively developed. However, it has been hard to avoid inflammation at the administration site because these methods partially destroy the skin tissue. On the other hand, TDDS with nanocarriers minimizing damage to the skin tissues has emerged together with the development of nanotechnology in recent years. This review focuses on current trends in TDDS. MDPI 2021-01-28 /pmc/articles/PMC7911274/ /pubmed/33525364 http://dx.doi.org/10.3390/nano11020335 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Uchida, Noriyuki Yanagi, Masayoshi Hamada, Hiroki Physical Enhancement? Nanocarrier? Current Progress in Transdermal Drug Delivery |
title | Physical Enhancement? Nanocarrier? Current Progress in Transdermal Drug Delivery |
title_full | Physical Enhancement? Nanocarrier? Current Progress in Transdermal Drug Delivery |
title_fullStr | Physical Enhancement? Nanocarrier? Current Progress in Transdermal Drug Delivery |
title_full_unstemmed | Physical Enhancement? Nanocarrier? Current Progress in Transdermal Drug Delivery |
title_short | Physical Enhancement? Nanocarrier? Current Progress in Transdermal Drug Delivery |
title_sort | physical enhancement? nanocarrier? current progress in transdermal drug delivery |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911274/ https://www.ncbi.nlm.nih.gov/pubmed/33525364 http://dx.doi.org/10.3390/nano11020335 |
work_keys_str_mv | AT uchidanoriyuki physicalenhancementnanocarriercurrentprogressintransdermaldrugdelivery AT yanagimasayoshi physicalenhancementnanocarriercurrentprogressintransdermaldrugdelivery AT hamadahiroki physicalenhancementnanocarriercurrentprogressintransdermaldrugdelivery |